Bayer is a global enterprise with core competencies in the Life Science fields of health care and agriculture.
Bayer is an innovation company with a more than 150-year history. Our scientific successes are intended to help improve people’s lives.
With our distinctive knowledge of people, animals and plants, we focus on the areas of health care and nutrition.
Read more about our economic, ecological and social challenges and opportunities.
This area provides news, videos and publications, as well as overviews of social media channels and mobile apps of the Bayer Group.
We want to create value for our shareholders through innovation, growth and high earning power.
Looking for a job in an innovative company? Learn more about Bayer and the opportunities available.
Bayer is a Life Science company with a more than 150-year history and core competencies in the areas of health care and agriculture. With our innovative products, we are contributing to finding solutions to some of the major challenges of our time.
An analysis by well-known branding agency Interbrand in 2015 valued the Bayer brand at €6.3 billion.
A growing and aging world population requires an adequate supply of food and improved medical care.
With our innovative products, we are contributing to finding solutions to some of the major challenges of our time. With life expectancy continuing to rise, we improve quality of life for a growing population by focusing our research and development activities on preventing, alleviating and treating diseases. We are also making an important contribution to providing a reliable supply of high-quality food, feed and plant-based raw materials.
Our goal is to create value for our customers, stockholders and employees, while also strengtheningthe company’s earning power. We are committed to operating sustainably and addressingour social and ethical responsibilities. Employees with a passion for innovation enjoy excellentdevelopment opportunities at Bayer. All this goes to make up our purpose:
Following the stock market flotation of Covestro, we reorganized the Bayer Group effective January 1, 2016, and are now focusing on our Life Science activities. These businesses hold leading positions in innovation-driven, rapidly growing markets.
Together, the Life Science businesses make up a strong, attractive and balanced portfolio that is resistant to fluctuations in demand and to potential risks. Our operations are managed in three divisions – Pharmaceuticals, Consumer Health and Crop Science – and the Animal Health business unit, which are also reporting segments.
The Pharmaceuticals Division focuses on prescription products, especially for cardiology and women’s healthcare, and on specialty therapeutics in the areas of oncology, hematology and ophthalmology. The division also comprises the radiology business, which markets diagnostic imaging equipment together with the necessary contrast agents.
The Consumer Health Division markets mainly nonprescription (OTC = over-the-counter) products in the dermatology, nutritional supplement, analgesic, digestive health, cold, allergy, sinus and flu, foot care and sun protection categories.
The Crop Science Division* is a world-leading agriculture enterprise with businesses in seeds, crop protection and nonagricultural pest control. The Crop Protection / Seeds operating unit markets a broad portfolio of high-value seeds and innovative pest management solutions, while at the same time providing extensive customer service for sustainable agriculture. The Environmental Science operating unit provides products and services for professional nonagricultural applications, such as vector and pest control and forestry.
Until the divestments to BASF due to regulatory demands are completed, Monsanto will operate independently from Bayer.
The Animal Health business unit ranks among the leading international innovators in its field. It develops and markets products and solutions for the prevention and treatment of diseases in companion and farm animals.
The corporate functions and Business Services operate as Group-wide competence centers in which business support services are bundled.
Currenta is the service company responsible for managing and operating the Chempark sites in Leverkusen, Dormagen and Krefeld-Uerdingen.
Covestro* is one of the world’s leading suppliers of high-tech polymer materials and develops innovative product solutions for a wide variety of everyday uses.
Dual governance system with the following governance bodies:
Board of Management:
seven members, Chairman: Werner Baumann
20 members, Chairman: Werner Wenning
With our products, we are contributing to finding solutions to some of the major challenges of our time. The growing and increasingly aging world population requires improved medical care and an adequate supply of food. Bayer is improving people’s quality of life by preventing, alleviating and curing diseases. And we are helping to provide a reliable supply of high-quality food, feed and plant-based raw materials.
Bayer’s extensive product portfolio contains numerous globally renowned brands.
The Bayer Group comprises 241 consolidated companies** in 79 countries throughout the world. Global headquarters are in Leverkusen, Germany.
** fully consolidated subsidiaries (as of October. 27, 2017)
On December 31, 2017, Bayer employed 99,820 (2016: 99,592) people worldwide. In Germany we had 31,620 (2016: 30,603) employees, which was 31.7% of the total Group workforce (2016: 30.7%).
figures restated1-6 for definition see footnotes to Bayer Group Key Data table
(as of Dec. 31, 2017)
Aging Population, big data, prenatal nutrition, water scarcity, animal-human bond: Bayer engages in a conversation about the future that matters the most to you – your own.